Related Experiment Video

Updated: Jul 1, 2026

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
08:46

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

5-Fluorouracil: mechanisms of resistance and reversal strategies

Ning Zhang1, Ying Yin, Sheng-Jie Xu

  • 1Department of Orthopaedics, 2nd Affiliated Hospital, School of Medicine, Zhejiang University, 310009, P.R. China. zhangning98@gmail.com

Molecules (Basel, Switzerland)
|September 17, 2008
PubMed

Insights

This review examines how 5-fluorouracil (5-FU) fights tumors and how resistance develops. It covers 5-FU

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Background:

  • 5-fluorouracil (5-FU) is a widely used chemotherapy agent.
  • Understanding its mechanisms of action and resistance is crucial for improving cancer treatment efficacy.
  • Drug resistance remains a significant challenge in 5-FU therapy.

Purpose of the Study:

  • To comprehensively review published research on the mechanisms of action of 5-fluorouracil.
  • To synthesize current knowledge on the development and characteristics of 5-fluorouracil resistance.
  • To explore novel methods, such as microarray techniques, for identifying genes associated with drug resistance.

Main Methods:

  • Literature review of published studies on 5-fluorouracil.
  • Analysis of research detailing anti-tumor action mechanisms.
  • Examination of studies investigating drug resistance pathways.
  • Review of methodologies for gene identification in drug resistance using microarrays.

Main Results:

  • Detailed elucidation of 5-fluorouracil's anti-tumor effects.
  • Comprehensive overview of various mechanisms contributing to 5-FU resistance.
  • Description of methods for inducing and reversing drug resistance.
  • Identification of gene discovery approaches for resistance mechanisms.

Conclusions:

  • A thorough understanding of 5-FU action and resistance is essential for optimizing chemotherapy.
  • Microarray techniques offer promising avenues for identifying novel resistance genes.
  • Further research into resistance mechanisms can guide the development of strategies to overcome 5-FU resistance.

More Related Videos

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down08:59

Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down

Published on: December 11, 2017

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform06:21

Multi-Gene Single Nucleotide Polymorphism Detection in Gastric Cancer Based on Ion Semiconductor Sequencing Platform

Published on: May 10, 2024

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...